Aska Pharmaceutical Co. Ltd. is a Japan company, located in Tokyo. more detail is as below. Company Information Company Name: Aska Pharmaceutical Co. Ltd.Country: JapanAddress: TokyoInternational Area Code: 81Phone: 03-5484-8361 (+81-03-5484-8361)Fax: 03-5484-8351 (+81-03-5484-8351)Website: www.aska-pharma.co.jpProfile: The Pharmaceutical Industry Is Committed To Making Contributions Toward The Health And Welfare Of People By Providing Highly Effective And Safe Pharmaceutical Products. Aska Pharmaceutical Co., Ltd. Was Founded On October 1, 2005 Through A Merger Of Teikoku Hormone Mfg. Co., Ltd. (founded 1920) And Grelan Pharmaceutical Co., Ltd. (founded 1930). Based On The Corporate Mission, “contribute Toward Improvement Of People’s Health And Progress In Medicine Through The Development Of Innovative Pharmaceutical Products,” The New Company Will, As A Research And Development (r&d) Oriented Company, Contribute To The Society By Developing And Providing Innovative Pharmaceutical Products With Concentrating Its Management Resources To The Specific Therapeutic Areas. The Circumstance Surrounding Healthcare Has Changed Greatly, As Seen By Events Such As The Advent Of A Super-aging Society And Dramatic Progress In Life Sciences. As A Result, The Role Of Pharmaceutical Products In The Society Has Become More And More Important. Under Such Circumstance, Aska Is Working To Establish The Infrastructure Of Drug Discovery Research And To Enhance The Development Of Internationally-acclaimed Pharmaceutical Products Through In-house Research And License-in Activities. Aska Will Also Establish An Advanced Quality Assurance System And Safety Measures In Order To Supply The Pharmaceutical Products With High Quality Continuously. Through These Efforts Aska Will Contribute To The Prosperous And Healthy Society. Your Continued Support And Cooperation Would Be Highly Appreciated.Area: Tokyo More Links Joetsu Electric Corp. Mitsubishi Chemical Media Co. Ltd. Aska Pharmaceutical Co. Ltd. Bosch Corporation Bosch Rexroth Corp. ‹ previous | next › Log in to post comments